Acquired von Willebrand syndrome: focused for hematologists [PDF]
Haematologica, 2020 The acquired von Willebrand syndrome (AvWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. However, unlike the inherited disease, AvWS occurs in persons with no personal and family history of ...
Massimo Franchini +1 more
doaj +5 more sources
Acquired von Willebrand syndrome: An update [PDF]
American Journal of Hematology, 2006 AbstractAcquired von Willebrand syndrome (aVWS) is a rare bleeding disorder with laboratory findings similar to those for congenital von Willebrand disease (VWD). However, unlike congenital VWD, it arises in individuals with no personal or family history of bleeding.
Franchini M, LIPPI, Giuseppe
openaire +4 more sources
A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology [PDF]
Research and Practice in Thrombosis and HaemostasisBackground: Acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder that usually mimics type 1 or 2A von Willebrand disease (VWD). Key Clinical Question: Can AVWS mimic the phenotype of type 2B VWD?
Simon Jaouen +5 more
doaj +2 more sources
Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia [PDF]
Annals of HematologyVenetoclax-obinutuzumab therapy successfully induced remission of acquired von Willebrand syndrome (AVWS) in a 72-year-old patient with chronic lymphocytic leukemia (CLL). Initially diagnosed with CLL, the patient later experienced severe bleeding due to
Francesca Morelli +5 more
doaj +2 more sources
Von Willebrand Disease in the elderly: clinical perspectives
Clinical Interventions in Aging, 2018 John Chapin Department of Hematology, Shire, Lexington, MA, USA Abstract: Von Willebrand disease (VWD) is an inherited bleeding disorder that affects up to 1% of the population. In most cases, VWD results from a mutation in the von Willebrand Factor (VWF)
Chapin J
doaj +1 more source
Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report
Journal of Blood Medicine, 2018 Candice M Baldeo, Candido E Rivera, Han W Tun, Prakash Vishnu Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA Abstract: von Willebrand disease (VWD) is a common bleeding disorder caused by defective or low ...
Baldeo CM, Rivera CE, Tun HW, Vishnu P
doaj +1 more source
Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH) [PDF]
Frontiers in Pediatrics, 2022 Background and objectivesEmerging evidence suggests that increased degradation of von Willebrand factor and decrease in high molecular weight multimers occurs in patients with pulmonary hypertension (PH). However, the link between acquired von Willebrand
Ivonne Wieland +6 more
doaj +2 more sources
Российский журнал гастроэнтерологии, гепатологии, колопроктологииAim: to present a clinical observation of a patient with Plummer — Vinson syndrome against the background of von Willebrand disease.Key points. A 40-years-old woman presented to the hematology department of our hospital with fatigue, dizziness, dyspnea ...
A. A. Saenko +7 more
doaj +2 more sources
Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005 [PDF]
, 2008 The prevalence, incidence and outcomes of haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopaenic purpura (TTP) are not well established in adults or children from prospective studies. We sought to identify both outcomes and current management
Todd, W.T.A. +3 more
core +4 more sources
Acquired Von Willebrand Syndrome following a SARS-CoV2 Infection. [PDF]
Acta Haematol, 2023 Acquired von Willebrand syndrome is a rare entity with approximately 700 cases described in the literature. Many etiologies are responsible for this condition, mainly lymphoproliferative and myeloproliferative syndromes, as well as cardiac diseases ...
Iarossi M, Hermans C.
europepmc +2 more sources